Thursday, February 24, 2011 10:11:37 AM
China’s Guangzhou TV building utilizes heat-reflective XIR® film to improve energy efficiency, maximize daylighting and increase occupant comfort
Press Release Source: Southwall Technologies Inc. On Thursday February 24, 2011, 9:00 am EST
PALO ALTO, Calif.--(BUSINESS WIRE)-- Southwall Technologies Inc. (OTCBB:SWTX.ob - News), the worldwide innovator of energy-saving films and glass products, today announced one of its largest architectural glass project wins, the Guangzhou TV building in China. Currently under construction alongside the world-renowned Guangzhou TV and Sightseeing Tower, the landmark building utilizes Southwall’s heat-reflective XIR film to minimize solar heat gain while maximizing visible light and energy efficiency. This is the second largest project win for Southwall in China after the Universiade Center sports complex in Shenzhen.
Southwall’s XIR film was selected for its clear solar control performance which saves energy while providing for optimal daylighting and a clean, architectural design. Laminated between 15 mm clear tempered low-iron glass covering 26,000 square meters (280,000 square feet) of the building envelope, the XIR film blocks over 50 percent of the sun’s heat (shading coefficient of 0.49) with visible light transmission of greater than 60 percent, providing a cool and comfortable environment that lowers HVAC system loads and operating costs. The XIR film maximizes clarity with reflectance of just eight percent and reduces interior fading by blocking 99.5 percent of UV rays. The monolithic nature of the glass also brings additional safety and flexible glazing design benefits.
“With our heat-reflective XIR film, we are proud to equip the Guangzhou TV building with unequaled protection from the sun’s heat while providing superior daylighting and energy-efficiency,” said Dennis Capovilla, president and chief executive officer of Southwall Technologies. “This landmark project represents one of the largest architectural glass projects in our company’s history, signaling our continued growth within the global marketplace.”
The high-performance XIR laminated glass is being specified and supplied by Shenzhen Kaisheng Energy Saving Technology Co. Ltd, Southwall’s Master Distributor of Architectural XIR products in China. Glazed monolithically or combined into sealed insulating glass units, XIR film enables a unique, low-reflectance appearance while blocking approximately 50 percent of invisible heat. Unlike glass coatings, XIR film was developed specifically to support the laminating process and can be laminated with low-iron, annealed, heat-strengthened or tempered clear glass, or combined with tinted PVB and tinted glass for maximum design flexibility.
To learn more about Southwall Technologies and its energy-saving films and glass products, visit www.southwall.com.
About Southwall Technologies
Southwall Technologies Inc. is recognized as a leader in the development and manufacture of high performance, energy-saving films and glass products that dramatically improve the energy efficiency of residential, commercial and automotive glass. Southwall is an ISO 9001:2000/14001 certified manufacturer with customers in over 25 countries.
Recent SWTX News
- SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology • GlobeNewswire Inc. • 11/11/2024 11:30:11 AM
- SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting • GlobeNewswire Inc. • 11/07/2024 11:30:00 AM
- SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference • GlobeNewswire Inc. • 11/05/2024 12:00:32 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/26/2024 01:46:32 AM
- SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 • GlobeNewswire Inc. • 10/22/2024 11:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:26:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:09:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:05:26 PM
- FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN • GlobeNewswire Inc. • 08/28/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:36:23 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:34:23 AM
- SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/07/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:45 PM
- SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors • GlobeNewswire Inc. • 07/29/2024 10:30:11 AM
- SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 • GlobeNewswire Inc. • 07/23/2024 11:00:02 AM
- Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm • PR Newswire (US) • 07/02/2024 04:49:00 PM
- SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 07/01/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:07:38 PM
- SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:00:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:37:20 PM
- SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:53:56 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM